Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignanciesRINTALA, E.Scandinavian journal of infectious diseases. 1994, Vol 26, Num 1, pp 77-84, issn 0036-5548Article

CHRONIC OCCUPATIONAL EXPOSURE TO TOLUENETAEHTI H; KAERKKAEINEN S; PYYKKOE K et al.1981; INT. ARCH. OCCUP. ENVIRON. HEALTH; ISSN 0340-0131; DEU; DA. 1981; VOL. 48; NO 1; PP. 61-69; BIBL. 23 REF.Article

Value of measurement of C-reactive protein in febrile patients with hematological malignanciesRINTALA, E; IRJALA, K; NIKOSKELAINEN, J et al.European journal of clinical microbiology & infectious diseases (Print). 1992, Vol 11, Num 11, pp 973-978, issn 0934-9723Article

Group II phospholipase A₂ in sera of febrile patients with microbiologically or clinically documented infectionsRINTALA, E. M; NEVALAINEN, T. J.Clinical infectious diseases. 1993, Vol 17, Num 5, pp 864-870, issn 1058-4838Article

Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancyRINTALA, E. M; NEVALAINEN, T. J.European journal of haematology. 1993, Vol 50, Num 1, pp 11-16, issn 0902-4441Article

Late steroid therapy in primary acute lung injuryVARPULA, T; PETTILÄ, V; RINTALA, E et al.Intensive care medicine (Print). 2000, Vol 26, Num 5, pp 526-531, issn 0342-4642Article

Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignanciesRINTALA, E; PULKKI, K; MERTSOLA, J et al.Scandinavian journal of infectious diseases. 1995, Vol 27, Num 1, pp 39-43, issn 0036-5548Article

Detection of messenger RNA for the β-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reactionHOTAKAINEN, K; LINTULA, S; STENMAN, J et al.International journal of cancer. 1999, Vol 84, Num 3, pp 304-308, issn 0020-7136Article

Protein C in the treatment of coagulopathy in meningococcal diseaseRINTALA, E; SEPPÄLÄ, O.-P; KOTILAINEN, P et al.Critical care medicine. 1998, Vol 26, Num 5, pp 965-968, issn 0090-3493Article

Antimicrobial therapy of septicemic patients in intensive care units before and after blood culture reportingRINTALA, E; KAIRISTO, V; EEROLA, E et al.Scandinavian journal of infectious diseases. 1991, Vol 23, Num 3, pp 341-346, issn 0036-5548Article

Early identification of bacteremia by biochemical markers of systemic inflammationRINTALA, E. M; AITTONIEMI, J; LAINE, S et al.Scandinavian journal of clinical & laboratory investigation. 2001, Vol 61, Num 7, pp 523-530, issn 0036-5513Article

Neoadjuvant chemotherapy in bladder cancer : a randomized study : nordic cystectomy trial IRINTALA, E; HANNISDAHL, E; FOSSÅ, S. D et al.Scandinavian journal of urology and nephrology. 1993, Vol 27, Num 3, pp 355-362, issn 0036-5599Article

Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. CommentaryRINTALA, E; JAUHIAINEN, K; KAASINEN, E et al.The Journal of urology. 1996, Vol 156, Num 1, pp 56-60, issn 0022-5347Article

Results of a randomized phase iii trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. CommentaryWITJES, J. A; CARIS, C. T. M; MUNGAN, N. A et al.The Journal of urology. 1998, Vol 160, Num 5, pp 1668-1672, issn 0022-5347Article

Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapyHELLSTEN, S; RINTALA, E; WAHLQVIST, R et al.European urology. 1998, Vol 33, pp 35-38, issn 0302-2838, SUP4Conference Paper

Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-α2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinomaKAASINEN, E; RINTALA, E; PERE, A.-K et al.The Journal of urology. 2000, Vol 164, Num 1, pp 47-52, issn 0022-5347Article

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy : Nordic cystectomy trial IMALMSTRÖM, P.-U; RINTALA, E; WAHLQVIST, R et al.The Journal of urology. 1996, Vol 155, Num 6, pp 1903-1906, issn 0022-5347Article

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer : A prospective comparative studyLIUKKONEN, T; RAJALA, P; RAITANEN, M et al.European urology. 1999, Vol 36, Num 5, pp 393-400, issn 0302-2838Conference Paper

Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancerHOTAKAINEN, K; BJARTELL, A; SANKILA, A et al.International journal of oncology. 2006, Vol 28, Num 1, pp 95-101, issn 1019-6439, 7 p.Article

Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluidKOTILAINEN, P; JALAVA, J; MEURMAN, O et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 8, pp 2205-2209, issn 0095-1137Article

Prospective randomized trial of interferon Alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancerPYRHÖNEN, S; SALMINEN, E; RUUTU, M et al.Journal of clinical oncology. 1999, Vol 17, Num 9, pp 2859-2867, issn 0732-183XArticle

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment : a prospective and randomized clinical trial of 381 patientsRUOTSALAINEN, E; JÄRVINEN, A; KOIVULA, I et al.Journal of internal medicine. 2006, Vol 259, Num 2, pp 179-190, issn 0954-6820, 12 p.Article

Randomized controlled study of chemoprophylaxis in transurethral prostatectomyVIITANEN, J; TALJA, M; ELO, J et al.The Journal of urology. 1993, Vol 150, Num 5, pp 1715-1717, issn 0022-5347, 2Article

Transurethral resection with perioperative instillation of interferon-α or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer : A prospective randomized multicenter study-Finnbladder III. CommentariesRAJALA, P; LIUKKONEN, T; RAITANEN, M et al.The Journal of urology. 1999, Vol 161, Num 4, pp 1133-1136, issn 0022-5347Article